Propharex (PROP) - Financial and Strategic Analysis ReviewPropharex is a specialty pharmaceutical company specialized in the conception, the construction, the delivery and the assembly of "turnkey" modular pharmaceutical plants. The company supplies raw materials to pharmacies which are involved in pharmacy compounding on the Belgian market. While supplying raw materials, it ensures quality control, and repacks them into smaller containers...more
Zhongtian International Limited (2379) - Financial and Strategic Analysis ReviewZhongtian International Limited (Zhongtian International) is an investment holding company engaged in trading of software and hardware products. The company also offers applications and maintenance, system integration and software training services. In addition, the company also offers services related to property development and consultancy. The company is mainly...more
Giaconda Limited (GIA) - Financial and Strategic Analysis ReviewGiaconda Limited (Giaconda) is a research focused biotechnology company, engaged in research, development and commercialization of innovative therapeutics for gastrointestinal diseases and disorders. The company focuses broadly on research and development activities in the area of digestive diseases. The pipeline products of the company includes Myoconda, Hepaconda, Heliconda and Ibaconda, and one bowel evacuant Picoconda. Myoconda is a combination antibiotic therapy being developed in Phase III clinical trial for the treatment of crohns disease. Hepaconda is a combination of bezafibrate and chenodeoxycholic acid.This comprehensive SWOT profile of Giaconda Limited provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of the Profile on Demand...more
CytoDyn, Inc. (CYDY) - Financial and Strategic Analysis ReviewCytoDyn, Inc. (CytoDyn) is a biotechnology research company that is engaged in the development of drugs to treat HIV/AIDS. The company is a member of New Mexico Biotechnology and Biomedical Association. CytoDyn's product folio includes Cytolin for HIV/AIDS. It's Cytolin is a monoclonal...more
Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic Analysis ReviewIntellect Neurosciences, Inc. (Intellect Neuro) is a US based biopharmaceutical company. Intellect Neuro is in development stage. The company is engaged in the discovery and development of therapeutic products for the treatment and prevention of Alzheimer's disease and...more
QRxPharma Limited (QRX) - Financial and Strategic Analysis ReviewQRxPharma Limited (QRxPharma) is clinical-stage specialty pharmaceutical company. The company is engaged in the development, manufacture and sale of products pertaining to pain management and central nervous system disorders therapy areas. Its products under investigation include MoxDuo CR, MoxDuo IR and MoxDuoIV. Its lead drug candidate MoxDuo IR is being developed in Phase III clinical trial for the treatment of acute management of moderate to severe pain. MoxDuoIV and MoxDuo CR are in Phase II and Phase I clinical trials respectively. In addition, the company investigating T9001, Haempatch and Textilinin in Pre clinical stage of development.QRxPharma Limited Key Recent DevelopmentsApr 14, 2010: QRxPharma Completes Phase 3 Combination Rule Study Of MoxDuoIRMar 30, 2010: QRxPharma Begins MoxDuo CR Phase 1 TrialFeb 24, 2010: QRxPharma, China Aoxing Enter Into Strategic Alliance For MoxDuo IVFeb 23, 2010: QrxPharma And China Aoxing Partner For Development Of MoxDuoIVFeb 10, 2010: QRxPharma Begins MoxDuoIR Second Phase 3 TrialThis comprehensive SWOT profile of QRxPharma Limited provides you an in-depth strategic...more
Omeros Corporation (OMER) - Financial and Strategic Analysis ReviewOmeros Corporation (Omeros) is the US based clinical-stage bio-pharmaceutical company. It is engaged in the discovery, development and commercialization of products which are focused...more
Sosei Co. Ltd. (4565) - Financial and Strategic Analysis ReviewSosei Co. Ltd., (Sosei)is a privately held company that is engaged in the process of drug development. The product pipeline of the company is supplemented by in-licensing agreements for...more
Laboratorios Farmaceuticos ROVI, S.A. (ROVI) - Financial and Strategic Analysis ReviewLaboratorios Farmaceuticos ROVI, S.A. (Laboratorios Farmaceuticos) is a chemical and pharmaceutical company. The company is engaged in the research, development,...more
BioStar Pharmaceuticals, Inc. (BSPM) - Financial and Strategic Analysis ReviewBioStar Pharmaceuticals, Inc. (BioStar) is a pharmaceutical company engaged in development, manufacture, and marketing of pharmaceutical and medical nutrient products for...more
Cryo-Save Group N.V. (CRYO) - Financial and Strategic Analysis ReviewCryo-Save Group N.V. (Cryo-Save) is a biotechnology company engaged in the collection and storage of adult stem cells derived from cord blood, umbilical and adipose tissue. The...more
Fashion Shoes are a necessary evil that people like to shop for, especially for guys. Wandering from shoe store to fashion shoe store is hardly the way to spend a perfectly good Sunday afternoon. The good news is that men no longer have to resort to...more